Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1470540Generated: October 30, 2026

Hydrochloric Acid → (S)-4-(4-hydrazinobenzyl)-2-oxazolidinone

https://huagongshe.com/reaction/1470540

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
ReactantZolmitriptanHCID 60857—
Reactant(S)-4-(4-Aminobenzyl)oxazolidin-2-oneHCID 7099156—
ReactantSodium NitriteHCID 23668193—
Product(S)-4-(4-hydrazinobenzyl)-2-oxazolidinoneHCID 9990596—

Reaction Steps

Zolmitriptan was first disclosed in U.S. Pat. No. 5,466,699 and the synthetic route comprises diazotization of (S)-4-(4-aminobenzyl)-1,3-oxazolidin-2-one with sodium nitrite in presence of hydrochloric acid, followed by treatment of the diazonium salt with stannous chloride to give (S)-4-(4-hydrazinobenzyl)-1,3-oxazolidin-2-one. Further reaction of the hydrazine derivative with dimethylamino butyraldehyde diethyl acetal followed by chromatographic purification gave Zolmitriptan (I) as oil, which upon further crystallization from isopropanol gave Zolmitriptan of desired purity. (S)-4-(4-aminobenzyl)-1,3-oxazolidin-2-one, in turn, was obtained from L-4-nitrophenyl alanine by treating it with thionyl chloride and methanol to give (S)-methyl-4-nitrophenyl alanate, which on reduction with sodium borohydride gave the corresponding alcohol. Further reaction of the said alcohol with phosgene in presence of potassium hydroxide followed by hydrogenation in presence of palladium on carbon gave the desired (S)-4-(4-aminobenzyl)-1,3-oxazolidin-2-one.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09006453B2
Source datasetuspto-grants-2015_04
ORD IDord-95155dbb31184755aedbd79a74f242d2
Source noteuspto-grants-2015_04